Lavista Ideal Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 Cr
- Revenue Growth 5.63%
- Profit Growth 0.13%
- Ebitda 15.98%
- Net Worth 46.13%
- Total Assets 27.97%
About Lavista Ideal Pharmacy
Lavista Ideal Pharmacy Private Limited (LIPPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 May 2017 (Seven years and nine months 0 days old ). Its registered office is in Solan, Himachal Pradesh, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹4.00 Cr.
Sukhpreet Singh, Ritesh Rai, and Himanshu Verma serve as directors at the Company.
Company Details
-
Location
Solan, Himachal Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999HP2017PTC006596
-
Company No.
006596
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 May 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Himachal Pradesh
Industry
Who are the key members and board of directors at Lavista Ideal Pharmacy?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sukhpreet Singh
|
Whole-Time Director | 28-Oct-2021 | Current |
|
Ritesh Rai
|
Director | 05-May-2017 | Current |
|
Himanshu Verma
|
Director | 28-Oct-2021 | Current |
Financial Performance of Lavista Ideal Pharmacy.
Lavista Ideal Pharmacy Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 5.63% increase. The company also saw a slight improvement in profitability, with a 0.13% increase in profit. The company's net worth Soared by an impressive increase of 46.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lavista Ideal Pharmacy?
Unlock access to Lavista Ideal Pharmacy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Lapoo Pharmachem Private LimitedSukhpreet Singh is a mutual person
-
Albro Pharmaceuticals Pvt Ltd
Ritesh Rai is a mutual person
Charges (Loans)
₹40.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 3.00 Cr
- Axis Bank Limited : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Aug 2024 | Others | ₹2.00 Cr | Open |
| 06 Aug 2024 | Others | ₹1.00 Cr | Open |
| 14 Mar 2023 | Axis Bank Limited | ₹1.00 Cr | Open |
How Many Employees Work at Lavista Ideal Pharmacy?
Lavista Ideal Pharmacy has a workforce of 3 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lavista Ideal Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lavista Ideal Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
